Your browser doesn't support javascript.
loading
Risk Assessment of Sarcopenia in Patients With Type 2 Diabetes Mellitus Using Data Mining Methods.
Cui, Mengzhao; Gang, Xiaokun; Gao, Fang; Wang, Gang; Xiao, Xianchao; Li, Zhuo; Li, Xiongfei; Ning, Guang; Wang, Guixia.
Affiliation
  • Cui M; Department of Endocrinology and Metabolism, The First Hospital of Jilin University, Changchun, China.
  • Gang X; Department of Endocrinology and Metabolism, The First Hospital of Jilin University, Changchun, China.
  • Gao F; College of Computer Science and Technology, Jilin University, Changchun, China.
  • Wang G; Department of Endocrinology and Metabolism, The First Hospital of Jilin University, Changchun, China.
  • Xiao X; Department of Endocrinology and Metabolism, The First Hospital of Jilin University, Changchun, China.
  • Li Z; Department of Endocrinology and Metabolism, The First Hospital of Jilin University, Changchun, China.
  • Li X; College of Computer Science and Technology, Jilin University, Changchun, China.
  • Ning G; Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health of China, Shanghai National Clinical Research Center for Endocrine and Metabolic Diseases, Shanghai Institute for Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, Ch
  • Wang G; Department of Endocrinology and Metabolism, The First Hospital of Jilin University, Changchun, China.
Article in En | MEDLINE | ID: mdl-32210921
Purpose: Sarcopenia is a geriatric syndrome, and it is closely related to the prevalence of type 2 diabetes mellitus (T2DM). Until now, the diagnosis of sarcopenia requires Dual Energy X-ray Absorptiometry (DXA) scanning. This study aims to make risk assessment of sarcopenia with support vector machine (SVM) and random forest (RF) when DXA is not available. Methods: Firstly, we recruited 132 patients aged over 65 and diagnosed with T2DM in Changchun, China. Clinical data were collected for predicting sarcopenia. Secondly, we selected 3, 5, and 7 features out of over 40 features of patient's data with backward selection, respectively, to train SVM and RF classification models and regression models. Finally, to evaluate the performance of the models, we performed leave one out and 5-fold cross validation. Results: When training the model with 5 features, the sensitivity, specificity, negative predictive value (NPV) and positive predictive value (PPV) were favorable, and it was better than the models trained with 3 features and 7 features. Area under the receiver operating characteristic (ROC) curve (AUC) were over 0.7, and the mean AUC of SVM models was higher than that of RF. Conclusions: Using SVM and RF to make risk assessment of sarcopenia in the elderly is an option in clinical setting. Only 5 features are needed to input into the software to run the algorithm for a primary assessment. It cannot replace DXA to diagnose sarcopenia, but is a good tool to evaluate sarcopenia.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Algorithms / Diabetes Mellitus, Type 2 / Sarcopenia / Data Mining Type of study: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male Country/Region as subject: Asia Language: En Journal: Front Endocrinol (Lausanne) Year: 2020 Document type: Article Affiliation country: China Country of publication: Switzerland

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Algorithms / Diabetes Mellitus, Type 2 / Sarcopenia / Data Mining Type of study: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male Country/Region as subject: Asia Language: En Journal: Front Endocrinol (Lausanne) Year: 2020 Document type: Article Affiliation country: China Country of publication: Switzerland